Latest Articles
Changes to Rx Economics – What Employers Should Know
New requirements that take effect in the next few years may give employers more insight into pharmacy economics, but more data doesn't automatically mean more clarity
Read More
5 Pharmacy Benefit Trends Employers Need to Watch
Emerging therapies, rising costs, and new regulations are changing how employers plan and manage pharmacy benefits
Read More
Capital Blue Cross Collaborates with Mark Cuban Cost Plus Drug Co. to Cover Biosimilars
Expanding access to lower‑cost specialty medications for employers and members
Read More
How Health Plans Decide Which Drugs to Cover – and Why It Matters to Employers
A look at the process behind Capital's decision to cover the new Wegovy oral GLP-1 and other medications like it.
Read More
Why Smart Employers Play the Long Game with Pharmacy Strategy
Learn why employers that look beyond quick fix pharmacy trends gain better cost control, better outcomes — and a clearer path to sustainable benefits
Read More
Should GLP-1 Drugs Be Covered? 4 Facts for Employers to Consider
There's a surge in demand for drugs like Ozempic, Wegovy, and Zepbound for weight loss. If you're an employer considering whether to cover these drugs for your employees, taking a...
Read More
Who’s Your Health Plan Really Working For? The Case for Conflict-of-Interest-Free Pharmacy Benefits
Employers are moving away from vertically integrated insurance plans and choosing open, conflict‑free pharmacy benefit models that prioritize lower costs, flexibility, and member outcomes.
Read More
The Data is Clear: Integrating Medical and Rx Benefits Drives Better Outcomes and Lower Costs
See how Capital’s fully integrated health benefits model uncovers insights, reduces risks, and closes gaps in care.
Read More